Inventor
MORSEY MOHAMAD
US26 patents
⚠️ This page may combine multiple inventors who share the name “MORSEY MOHAMAD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTERVET INC
24 patentsUS10106607B2Oct 23, 2018
Caninized antibodies
INTERVET INC22 citations93
US10023636B2Jul 17, 2018
Caninized murine antibodies to human PD-1
INTERVET INC5 citations83
US9944704B2Apr 17, 2018
Antibodies against canine PD-1
INTERVET INC8 citations82
US9409954B2Aug 9, 2016
Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
INTERVET INC7 citations82
US8932604B2Jan 13, 2015
Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
INTERVET INC10 citations82
US11248047B2Feb 15, 2022
Caninized antibodies
INTERVET INC2 citations72
US11091556B2Aug 17, 2021
Caninized human antibodies to human IL-4R alpha
INTERVET INC2 citations72
US10927172B2Feb 23, 2021
Caninized murine antibodies to human PD-1
INTERVET INC2 citations72
US11680097B2Jun 20, 2023
Antibodies against canine PD-1
INTERVET INC2 citations71
US11596687B2Mar 7, 2023
Recombinant non-pathogenic Marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens
INTERVET INC3 citations71
US11447561B2Sep 20, 2022
PD-L1 antibodies binding canine PD-L1
INTERVET INC2 citations71
US11229698B2Jan 25, 2022
Recombinant non-pathogenic Marek's Disease virus constructs encoding multiple heterologous antigens
INTERVET INC5 citations71
US10711061B2Jul 14, 2020
Antibodies against canine PD-1
INTERVET INC2 citations71
US10550194B2Feb 4, 2020
PD-L1 antibodies binding canine PD-L1
INTERVET INC2 citations71
US12545738B2Feb 10, 2026
Canine interleukin-4 receptor alpha antibodies
INTERVET INC0 citations62
US12435143B2Oct 7, 2025
Caninized antibodies against canine CTLA-4
INTERVET INC0 citations62
US12252536B2Mar 18, 2025
Caninized antibodies
INTERVET INC0 citations62
US12221486B2Feb 11, 2025
Caninized human antibodies to human IL-4R alpha
INTERVET INC0 citations62
US12180288B2Dec 31, 2024
Antibodies to canine interleukin-4 receptor alpha
INTERVET INC0 citations62
US12239704B2Mar 4, 2025
Recombinant non-pathogenic Marek's disease virus constructs encoding multiple heterologous antigens
INTERVET INC0 citations61
US12514922B2Jan 6, 2026
Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens
INTERVET INC0 citations60
US12552864B2Feb 17, 2026
Caninized antibodies to human CTLA-4
INTERVET INC0 citations51
US10858437B2Dec 8, 2020
Antibodies to canine interleukin-4 receptor alpha
INTERVET INC0 citations51
US12577310B2Mar 17, 2026
Caninized antibodies to canine interleukin-31 receptor alpha
INTERVET INC0 citations44